Mutations in the gene encoding isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) were identified across several cancer types including gliomas, chondrosarcoma, and hematological malignancies [85,86,87,88,89,90]. Here, IDH2 is linked to central nervous system cancer.